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Objectives: To describe the access to the interventions for the prevention of Human Immun-
odeﬁciency  Virus (HIV) mother to child transmission and mother to child transmission rates
in  the outskirts of Rio de Janeiro, from 1999 to 2009.
Methods: This is a retrospective cohort study. Prevention of HIV mother to child transmission
interventions  were accessed and mother to child transmission rates were calculated.
Results: The study population is young (median: 26 years; interquartile range: 22.0–31.0), with
low monthly family income (40.4% up to one Brazilian minimum wage) and schooling (62.1%
less  than 8 years). Only 47.1% (n = 469) knew the HIV status of their partner; of these women,
39.9%  had an HIV-seronegative partner. Among the 1259 newborns evaluated, access to the
antenatal, intrapartum and postpartum prevention of HIV mother to child transmission
components  occurred in 59.2%, 74.2%, and 97.5% respectively; 91.0% of the newborns were
not  breastfed. Overall 52.7% of the newborns have beneﬁted from all the recommended
interventions. In subsequent pregnancies (n = 289), 67.8% of the newborns received the full
package of interventions. The overall rate of HIV vertical transmission was 4.7% and the
highest  annual rate occurred in 2005 (7.4%), with no deﬁnite trend in the period.
Conclusions: Access to the full package of interventions for the prevention of HIV verticaltransmission  was low, wi
cal  transmission rates ob
municipality  of Rio de Jan
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ntroduction
razil was  the ﬁrst developing country to implement a
ational  program to prevent HIV mother to child transmission
PMTCT). HIV Counseling and testing, access to antiretroviral
herapy (ART) and infant formula to substitute breastfeed-
ng  have been universally provided free-of-charge. Although
MTCT  is considered as a high priority by the Brazilian
inistry of Health (BMH), it remains a relevant problem in
he  country1 with a signiﬁcant number of new pediatric
ases continuing to occur annually.2 In Brazil, between 1980
nd  June 2011, 13,540 cases of vertical transmission were
eported;  from January 2010 to June 2011, 457 new cases were
otiﬁed.2
In Brazil, initial studies showed a MTCT rate of 16%,3
ut there has been a signiﬁcant decrease over recent years.
n  a national multicenter study covering 2924 children,4 the
TCT  rate was  8.6% in 2000 and 7.1% in 2001, with signiﬁ-
ant  regional differences, with less antiretroviral use during
regnancy  in the north and northeast regions leading to
igher  rates of transmission. Studies conducted in the recent
ears  still show striking regional disparities, with MTCT rates
f  between 2.4% and 4.9% in the southern and southeast
egions, the wealthiest parts of Brazil,5–8 and transmission
ates as high as 9.1 and 9.9 in the northeast and northern
egions.9–11
The shortcomings of the health system highly impact the
uccess  of interventions for MTCT12 and this is even more  crit-
cal  in developing countries. Barriers to the implementation
f the several interventions that are part of the prevention
ackage for HIV MTCT (MTCT) as well as the programmatic
esults obtained vary regionally across the country.8 Rio de
aneiro  ranks second in the number of reported AIDS cases in
razil.
Although it is located in one of the most industrialized
egions of the country, a large disparity still exists between
he  rich areas and the poor peripheral regions surrounding the
apital  city. The highest incidence of AIDS cases in the state
s  found in a region called Baixada Fluminense, an impov-
rished  area in the outskirts of Rio de Janeiro, inhabited by
our  million marginalized individuals who are plagued by vio-
ence, poverty, social injustice, and endemic and epidemic
iseases. Baixada Fluminense integrates 13 municipalities of
hich  Nova Iguac¸u  has the highest population density and
erritory.13 Among the 92,089 individuals diagnosed with AIDS
n  Rio de Janeiro State between 1982 and 2012, 18,903 were
rom  Baixada Fluminense.14
This study describes the cascade of access to the rec-
mmended interventions for PMTCT and the rates of MTCT
mong  HIV-infected pregnant women in a metropolitan area
f  Rio de Janeiro, Brazil.
ethodologyhe HIV Family Care Clinic (HHFCC) operates within Hospi-
al  Geral de Nova Iguac¸u  (HGNI), the largest public hospital
n  Baixada Fluminense. HHFCC is the main referral cen-
er  for HIV-infected pregnant women  and their infants and4;1 8(3):252–260  253
provides  free access to antiretrovirals (ARVs) and services for
the  prevention of MTCT. Considering 0.59% the HIV preva-
lence  among women between 15 and 49 years,15 rate that
has  been stable since 2004,2 and the number of stillbirths in
2011,16 we estimated approximately 1300 as the number of
HIV  pregnant women assisted in Rio de Janeiro in that year;
among  those, 165 (12.7%) received care in HHFCC-HGNI. A ret-
rospective  cohort of HIV-infected pregnant women and their
newborns  was  established at the HHFCC-HGNI in collabora-
tion  with the Instituto de Pesquisa Clinica Evandro Chagas –
IPEC, Fiocruz.
In  the present study, all HIV-infected pregnant women  and
their  newborns who received care at the HHFCC between
01/01/1999 and 31/12/2009 were  included. Retrospective chart
review  using a structured case report form was conducted. The
project  was  approved by the HGNI (CAAE: 0005.1.316.000-07)
Ethics in Research Committee.
Study  deﬁnitions
Recommended package of interventions for HIV PMTCT
according to the timing of HIV diagnosis in the pregnant
women:
a)  HIV diagnosis before and during pregnancy: antenatal
antiretroviral therapy (ART) + intrapartum IV Zidovudine
(ZDV) + ZDV syrup + formula for the newborn;
b)  HIV diagnosis at labor/delivery: intrapartum IV ZDV + ZDV
syrup  + formula for the newborn;
(c)  HIV diagnosis during the immediate postpartum: ZDV
syrup  + formula for the newborn.
HIV-positive newborns were deﬁned as follows: two pos-
itive  HIV diagnostic tests (using either the quantiﬁcation of
plasma  HIV RNA (HIV viral load) or detection of proviral DNA)
performed  between 1 and 6 months of age, with one of them
sampled  after 4 months of age. For those children without a
deﬁned diagnosis who were  over 18 months of age, two pos-
itive  serology samples for anti-HIV-1 and -2 or two positive
rapid  tests using different methodologies were  required.17,18
HIV-negative newborns were deﬁned as follows: two neg-
ative  HIV diagnostic tests (using either the quantiﬁcation of
plasma  HIV viral load or the detection of proviral DNA) were
performed  between 1 and 6 months of age, with one of them
sampled  after 4 months of age, plus a non-reactive anti-HIV
serology test after 12 months of age. For those children without
a  deﬁned diagnosis who were over 18 months of age, a nonre-
active  HIV serology or a negative result using two rapid tests
was  required. In discordant cases, a third test was  considered
to  reach a diagnostic conclusion.18
HIV-inconclusive newborns were deﬁned as follows: chil-
dren  who did not have one of above deﬁnitions were
considered as inconclusive for HIV serostatus, and the reason
may  be attributed to lost to follow-up or incomplete informa-
tion  in medical charts.
3CD4+  lymphocyte count at enrolment (cells/mm ): the ﬁrst
result  obtained at the entry in the cohort.
Skin color: this was  obtained from chart review and was
attributed by health professionals.
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Table 1 – Sociodemographic, clinical and obstetric
characteristics of women and pregnancies included in
the  study, 1999–2009.
Variables n %
Characteristics of pregnant women (n = 997)a
Age (years)
<18 43 4.3
18–24 346 34.7
25–35 515 51.7
>35 93 9.3
Skin color
White 270 27.1
Non white 727  72.9
Schooling (years)
<8  619 62.1
≥8 352 35.3
Data not available 26 2.6
Sexual partner HIV serostatus
No  sexual partner 24 2.4
Positive 282 28.3
Negative 187 18.8
Unknown 429 43.0
Data not available 75 7.5
Number of previous pregnancies
None  178 17.9
1 174 17.5
2 212 21.3
≥3 369 37.0
Data not available 64 6.4
Time of HIV testingb
Before pregnancy 199 20.0
During pregnancy 449 45.0
Intrapartum 177 17.8
Postpartum 171 17.2
Data not available 1 0.1
AIDS-CDC 1993
Yes  312 31.3
No 657 65.9
Data not available 28 2.8
CD4+ lymphocyte count at enrolment (cells/mm3)
<200 75 7.5
200–350 191 19.2
>350 511 51.3
Data not available 220 22.0
Characteristics of prenatal and delivery (n = 1269)a
Gestational age at the beginning of prenatal (weeks)
No prenatal visits 127 10.0
<14 227 17.9
14–28 507 40.0
>28 138 10.9
Data not available 270 21.3
Number of prenatal visits
None  127 10.0
1–3 241 19.0
4–6 526 41.4
≥7 311 24.5
Unknown 64 5.0
Maternity of delivery254  b r a z j i n f e c t d 
Statistical  analyses
Frequency, mean, standard deviation (SD), median and
interquartile range (IQR) were used to describe the socio-
demographic, behavioral and reproductive characteristics, as
well as those related to HIV/AIDS infection of women at entry
in  the cohort (n = 997) and also to describe the characteristics
of  the pregnancies which resulted in delivery in the cohort
(n  = 1269) between January 1999 and December 2009.
We described the municipality of residence for all women
included in the study and for the subgroup of women who did
not  receive prenatal care using maps generated by ESRI 2011
software  program only for illustrative purpose.19
Descriptive statistics were  used to describe access to pro-
phylactic  interventions to reduce the risk of perinatal HIV
transmission in this population, according to the moment of
maternal  mother HIV diagnosis. Trend analysis was  carried
out  in order to evaluate the access to recommended package
of  interventions according to the moment of maternal mother
HIV  diagnosis over time. The overall and annual rates of peri-
natal  HIV transmission were  also calculated.
Results
Overall, 997 women  were  included in the cohort with a total of
1326  pregnancies during the study period (1999–2009): 747 of
the  women  had only one pregnancy, 188 had two pregnancies,
46  had three pregnancies, 15 had four pregnancies and one had
ﬁve  pregnancies. In total, 329 subsequent pregnancies were
observed  among 250 women, of which 289 resulted in live-
birth  infants.
Of  all 1326 pregnancies observed in the cohort, 1269 (95.7%)
resulted  in delivery. Eighteen deliveries were  twins, resulting
in  a total of 1287 newborns. Of these, 97.9% (n = 1260) were
live-birth infants for whom the cascade of PMTCT interven-
tions  was  evaluated. Loss to follow-up during the antenatal
care  period occurred in 0.5% of all the pregnancies (Fig. 1).
The  characteristics of all women (n = 997) at the entry in the
cohort  are presented in Table 1. The majority of them resided
in  the municipality of Nova Iguac¸u  (41.1%), where HHFCC is
located,  followed by the municipalities of Belford Roxo (12.4%),
São  João de Meriti (9.5%), Queimados (9.1%), Rio de Janeiro
(6.9%)  and Duque de Caxias (5.7%) (Fig. 2). The median age was
26  years (IQR: 22.0–31.0); 39% of the women  were  younger than
24  years of age, 72.9% were non-white (Table 1). Approximately
62%  of them had less than 8 years of schooling, and 40.4% had
a  family income of up to one Brazilian minimum wage (varied
from  U$70.58 to U$234.46 during the study period).
Most of the women  (75.3%) lived with a partner at the
time  of cohort inclusion, but only 47.1% (n = 469) were  aware
of  the partner’s HIV serostatus. An HIV-1-infected partner
was  reported by 60.1%, while 39.9% were  in serodiscordant
relationships. The median number of pregnancies prior to
inclusion  in the cohort was  2.0 (IQR: 1.0–3.0). In total, 34.3%
(n  = 342) of the women reported having at least one abortion
prior  to inclusion in the cohort. Tobacco, alcohol and illicit
drug  use during pregnancy were reported by 24.0%, 23.6% and
5.0%  of the women, respectively. Heterosexual transmission
was  the predominant route of HIV infection acquisition; 30%
HGNI  960 75.7
Other institution 275 21.7
b r a z j i n f e c t d i s . 2 0 1 4;1 8(3):252–260  255
Table 1 (Continued)
Variables n %
Delivery outside the maternity 22 1.7
Data not available 12  0.9
Mode of delivery
Elective cesarean 531 41.8
Vaginal 514 40.5
Emergency cesarean 203 16.0
Data not available 21 1.7
Membranes at delivery
No  rupture 865 68.2
Rupture less than 3 h 88 6.9
Rupture between 3–6 h 81 6.4
Rupture more than 6 h 97 7.6
Rupture not knowing time 81 6.4
Data not available 57 4.5
Gestational age at delivery (weeks)
<37  185 14.6
≥37 1010 79.6
Data not available 74 5.8
a Total number of women included in the cohort (n = 997); Total
number of pregnancies that resulted in delivery in the cohort
(n = 1269).
b Time of HIV testing: the information is related to the ﬁrst preg-
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Spontaneous abortions – N=36 (2.7%)
Induced abortions – N=11 (0.8%)
Ectopic pregnancy – N=3 (0.2%)
Lost follow-up – N=6 (0.5%)
Maternal mortality – N=1 (0.1%)
Twin birth
N=18
Single birth
N=1,251
Stillbirths
N=27
Newborns
N=1,260
Births
N=1,269 
Children enrolled in the cohort
N=1,287
Pregnancies enrolled
N=1,326
Fig. 1 – Study ﬂowchart.
F
onancy in the cohort, e.g., the pregnancy at enrolment in the
cohort.
f the women  had been previously diagnosed with AIDS (CDC-
993)  upon cohort enrolment.
The mean TCD4+ lymphocyte count at enrolment was  486.8
SD:  258.7) cells/mm3; 65.8% of women had TCD4+ lymphocyte
ounts  higher than 350 cells/mm3 (Table 1). Approximately
0% of the women  were aware of their HIV serostatus when
hey  became pregnant. Among those who  were unaware of
heir  HIV serostatus when they became pregnant (n = 797),
6.3%  were diagnosed during prenatal care, 22.2% during
elivery and 21.5% during the immediate postpartum period
Table  1).The  characteristics of all pregnancies that resulted in deliv-
ry  in the cohort (n = 1269) are presented in Table 1. Prenatal
are  was  provided for 90% of these pregnancies, mostly within
Total of pregnant women (N=997)
Rio de janeiro
6.9%
Mesquita
5.1%
Nilópolis
2.4%
Duque de caxias
5.7%
Belford Roxo
12.4%
Paracambi
0.3%
Itaguai
1.2%
Queimados
9.1%
Nova lguaçu
41.1%Japeri
5.4%
10 5 0 10Km
Seropédica
0.8%
ig. 2 – Distribution of all women  (A) and women  who did not re
rigin.the municipality of Nova Iguac¸u  (65.4%). The mean gestational
age  at the start of prenatal care was  19.9 (SD = 7.7) weeks; in
40.0%  and 10.9% of the pregnancies, prenatal care was  initiated
between  14 and 28 weeks and after the 28th week, respectively.
Four  or more  prenatal care visits were made in 65.9% of the
pregnancies (Table 1).
The  majority of deliveries occurred at HGNI (75.7%). Elec-
tive  cesarean delivery (41.8%) and vaginal delivery (40.5%) were
the most common delivery methods. Spontaneous membrane
rupture  occurred in 27.3% of the deliveries that lasted longer
than  3 h and in at least 14% of all the deliveries. Preterm births
occurred  in 14.6% of the pregnancies (Table 1). One hundred
and  thirty-six women, with 157 pregnancies, did not have
access  to any prenatal care in at least one pregnancy in the
cohort.  The majority of them resided in the municipality of
Nova  Iguac¸u  (36.8%), followed by the municipalities of Rio de
Pregnant women who did not receive antenatal care (N=136)
(on at least one pregnacy while followed in the cohort)
Paracambi
0.0%
Itaguaí
0.0%
Seropédica
0.0%
Rio de janeiro
12.5%
Queimados
5.15%
Nova lguaçu
36.8%
Belford Roxo
10.3%
Mesquita
5.15%
Nilópolis
1.47%
Duque de caxias
11.8%Japeri
6.62%
10 5 0 10 20Km
ceive prenatal care (B) according to the municipality of
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Table 2 – PMTCT interventions delivered to pregnant women  and their newborns, 1999–2009 (n = 1259).
Interventions received by
newborns,  n (%)
Timing of HIV testing Total Subsequent pregnancies
Before pregnancy During pregnancy Labor Postpartum (n = 1259)f (n = 289)k,l
(n = 482)e,g (n = 435)h (n = 172)i (n = 170)j
ARV prophylaxis a + (IV)
ZDVb + formulac + ARV syrupd
339 (70.3) 324 (74.5) –  – 663 (52.7) 196 (67.8)
ARV prophylaxis a + (IV)
ZDVb + ARV syrupd
8 (1.7) 5 (1.1) – – 13 (1.0) 4 (1.4)
ARV prophylaxisa + formulac + ARV
syrupd
44 (9.1) 21 (4.8) – – 65 (5.2) 33 (11.4)
ARV prophylaxisa + ARV syrupd 2 (0.4) 3 (0.7) – 5 (0.4) 1 (0.3)
(IV) ZDVb + Formulac + ARV syrupd 41 (8.5) 63 (14.5) 125 (72.7) 229 (18.2) 23 (8.0)
(IV) ZDVb + Formulac – 1 (0.2) – – 1 (0.1) –
(IV) ZDVb + ARV syrupd 1 (0.2) 2 (0.5) 5 (2.9) 8 (0.6) –
Formulac + ARV syrupd 14 (2.9) 1 (0.2) 23 (13.4) 116 (68.2) 154 (12.2) 8 (2.8)
Only formulac 1 (0.2) – – – 1 (0.1) 1 (0.3)
Only ARV syrupd 2 (0.4) 1 (0.2) 9 (5.2) 49 (28.8) 61 (4.8) 1 (0.3)
None of the interventions 1 (0.2) – – 2 (1.2) 3 (0.2) 1 (0.3)
a ARV prophylaxis – ARV use during pregnancy.
b (IV) ZDV – intravenous zidovudine.
c Formula – newborns who were not breastfed and received infant formula.
d ARV syrup – ARV syrup administered to newborns.
e Among 482 newborns who were born to women diagnosed with HIV before pregnancy, 289 were born from subsequent pregnancies during
the study period.
f Of the 1260 newborns, data on timing of HIV testing of the women were available for 1259. Of the 1260 newborns, 53 had missing data in at
least one intervention and they do not appear in the table, as we could not deﬁne which set of interventions they received.
g Of the 482 newborns who were born to women diagnosed with HIV before pregnancy, 29 had missing data in at least one intervention and
we could not deﬁne which set of interventions they received. Among these 29, at least 8 received (IV) ZDV, 14 received formula and at least
17 received ARV syrup.
h Of the 435 newborns who were born to women diagnosed with HIV during pregnancy, 14 had missing data in at least one intervention and
we could not deﬁne which set of interventions they received. Among these 14, all of them received ARV prophylaxis, 8 received (IV) ZDV, 11
received formula and 6 received ARV syrup.
i Of the 172 newborns who were born to women diagnosed with HIV during delivery, 10 had missing data in at least one intervention and we
could not deﬁne which set of interventions they received. Among these 10, at least 4 received (IV) ZDV, 5 received formula and 6 received ARV
syrup.
j Of the 170 newborns who were born to women diagnosed with HIV during the postpartum period, 3 had missing data in at least one
intervention and we could not deﬁne which set of interventions they received. Among these 3, 2 received formula and all 3 received ARV
syrup.
k Of the 289 newborns from subsequent pregnancies in the cohort, 21 had missing data in at least one intervention and we could not deﬁne
elated
which set of interventions they received.
l One newborn died and did not receive ARV syrup. The death was r
Janeiro (12.5%), Duque de Caxias (11.8%), São João de Meriti
(10.3%)  and Belford Roxo (10.3%) (Fig. 2).
Among all newborns in the cohort with available data at
the  timing of maternal HIV diagnosis (n = 1259), only 47.6%
beneﬁted  from the recommended package of interventions for
PMTCT.
The antenatal care (ANC) components of the package
were  used by 59.2% (n = 746) of all pregnancies (n = 1259) in
this  cohort. The global coverage of intrapartum intravenous
zidovudine (IV ZDV) component was  74.1% (n = 934), and 97.5%
(n  = 1230) of the newborns had access to ZDV syrup; 85.5%
(n  = 1077) were  on antiretrovirals (ARVs) syrup for 6 weeks. Of
those, 10.1% had no data regarding duration of ARVs syrup
exposure. No breastfeeding (during their stay in the mater-
nity  ward)  was  observed in 91.0% (n = 1146) of the newborns
(Table  2).Of  the newborns who were  born to women diagnosed with
HIV  before or during pregnancy (n = 917) and who would there-
fore  have had the opportunity to receive the entire package to prematurity and hepatomegaly.
of  intervention recommended for PMTCT, 27.7% did not have
access  to it. Approximately 18% (n = 138) had no access to the
antenatal  component of the package and at least 10.4% (n = 95)
had  not received intrapartum IV ZDV. The vast majority of the
newborns  (95.3%) had access to infant formula (Table 2).
Among  the pregnant women diagnosed with HIV during
delivery and their newborns (n = 172), 72.7% received all of the
recommended interventions (IV ZDV, oral ZDV and no breast-
feeding)  (Table 2). Of the newborns who were  born to women
diagnosed with HIV during the immediate postpartum period
(n  = 171), only 67.8% received the recommended interventions.
ARVs  syrup was  used for 6 weeks by 86% (n = 147/171) of these
newborns  and for 6.5% there was no data available on the dura-
tion  of ARVs syrup exposure. One newborn of a mother whose
HIV  diagnosis antedated the current pregnancy and two new-
borns  of mothers diagnosed with HIV during the postpartum
period have not received any intervention (Table 2).
When  considering only the subsequent pregnancies in the
cohort  (n = 289), in which all women were already aware of
b r a z j i n f e c t d i s . 2 0 1 4;1 8(3):252–260  257
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heir HIV serostatus before becoming pregnant, only 67.8% of
hem  had access to the entire package of interventions recom-
ended  for PMTCT; almost 12% of them did not have access
o  the antenatal components of the interventions (Table 2).
Among  breastfed newborns (n = 91), information on breast-
eeding  duration was  available for 62 of them. Median and
ean  number of days of breastfeeding were 1 (IQR: 1–2) and
.3  (SD 12.6).
Regarding access to the recommended interventions
ccording to the timing of maternal HIV diagnosis and
ccording to the year of delivery, there was no apparent
rend towards accessing the cascade of interventions along
he  study period (before pregnancy: p = 0.12; during preg-
ancy:  p = 0.09; labor: p = 0.499; postpartum: p = 0.627) (data not
hown).  Of the live-birth infants whose mothers were diag-
osed  with HIV at delivery and during the postpartum period
n  2009, the last year of inclusion in the study, access to the rec-
mmended interventions remained unsatisfactory (80% and
7.7%,  respectively) (data not shown).
The annual coverage of IV ZDV administration to new-
orns  also ﬂuctuated globally over the years and according to
he time of maternal HIV diagnosis. In 2009, of the live-birth
nfants whose mothers were  diagnosed with HIV before or dur-
ng pregnancy and at delivery (n = 96), 22.9% had not received
his  intrapartum component.
The  overall rate of HIV MTCT during the study period was
.7%  (CI 95%: 3.5–5.9) (n = 1258). HIV serostatus could not be
etermined  in 223 (17.9%) newborns, due to lost to follow-up.
hen  the MTCT rate was  calculated using the assumption
hat the HIV infection rate was  the same for those newborns
n  whom an HIV diagnosis was  not determined, the estimated
verall  transmission rate was  5.3% (CI 95%: 4.1–6.5) (Fig. 3). The
ighest  annual rate occurred in 2005 (7.4%; CI 95%: 3.3–11.5),
ith  no deﬁnite trend in the period (data not shown). When
onsidering only breastfed newborns (n = 91), the MTCT rate
as  12.1% (CI 95%: 5.4–18.8), signiﬁcantly higher than the 3.9%ual MTCT rates, 1999–2009.
(CI 95%: 2.8–5.0) rate observed among the non-breastfed new-
borns  (n = 1167) (p = 0.0001).
Discussion
Our results shows that the HIV MTCT rates from 1999 to 2009
remained  high among women  who received ANC or delivered
at  this major referral center for PMTCT in the outskirts of Rio
de  Janeiro.
Several studies in Brazil have reported transmission rates
that  are consistent with the data found in our study,3,20–25
although lower MTCT rates have been achieved in wealthier
states  such as São Paulo,8 as a result of a better structured
health care system. Overall, the rates found in Brazil are higher
than  those reported from developed countries, where prophy-
lactic  measures are implemented early in pregnancy resulting
in  MTCT rates around 1%.26
When considering all newborns in the cohort (n = 1259),
only  52.7% of them beneﬁted from the complete package of
interventions  that are recommended for PMTCT. Again, this
result  is similar to that observed for Brazil as a whole (52%)
but  is much  lower than that observed in São Paulo where in
a  recent report there was 82% coverage for the entire pack-
age  of PMTCT interventions.8 Despite the broad knowledge in
place about the high effectiveness of ART during pregnancy
for  PMTCT27 and the universal availability of ARVs for this
purpose  in Brazil, access to the antenatal component was
observed  in only 59.2% of the ﬁrst pregnancies included in this
study. Late detection of HIV infection during prenatal care rep-
resents  an opportunity to intervene, thus limiting the number
of  pediatric cases as a result of perinatal transmission.28Access to HIV testing, the entry point for PMTCT during
antenatal care, may  be hampered by a series of events, which
result  in a delayed HIV diagnosis,27,29 leading to a longer
fetal exposure to the virus. In many  cases late diagnosis at
i s . 2 0
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delivery or postpartum30 leads to unacceptably high risk of
HIV  transmission. The lack of HIV diagnosis during preg-
nancy  represents only the ﬁrst step of a cascade of missed
opportunities. Of note, 26.6% of pregnancies in which HIV
infection  was  diagnosed before or during pregnancy have
not  even received one of the components of the prevention
package. Among these, 32.7% have not received the antenatal
component, and 9.8% have received the intrapartum compo-
nent.  Further studies are needed to identify strategies and
interventions to overcome the barriers in place and decrease
the  inequalities in access to PMTCT services.
Even more  worrisome is the ﬁnding that among the 289
subsequent pregnancies that resulted in live births during the
study  period, only 67.8% received the full package of PMTCT
interventions. It is especially disconcerting that almost 20%
of  these subsequent pregnancies have accessed the antena-
tal  component. Insufﬁcient linkage to care after delivery is a
well-recognized matter among HIV-infected women, and not
infrequently  they solely resume their contact with the health
services  at the time of delivery of a subsequent pregnancy.
Lack of integration of health services, notably between prena-
tal  and maternity care, may  have also accounted for part of
the  problem in regard to access to the intrapartum and post-
partum  components of the PMTCT intervention package. A
study conducted in Rio de Janeiro have indicated that approx-
imately  30% of pregnant women  unsuccessfully attempted to
be admitted to one or more  hospitals during labor,31 prior
to  admission for delivery, highlighting the fragile and frag-
mented  health system in place.
Breastfeeding was  observed in 9% of the newborns, simi-
lar  to the rate reported in a study from Pernambuco, in the
Northeast  region of Brazil10 and lower than the rate reported
in  Sergipe, in the same region,11 leading to a signiﬁcantly
higher MTCT rate among breastfed newborns when compared
to  those non-breastfed (12.1% vs. 3.9%). In a country where
formula  has long been provided free of charge to HIV infected
mothers,  breastfeeding may,  in fact, be more  of a marker of
poor  access to health care in general. Late HIV diagnosis of the
mother  leads to a lost opportunity of advising against breast-
feeding,  which is a major factor associated with MTCT,32 and
any  exposure to breast milk in itself constitutes a risk factor
for  transmission.
Several studies have conﬁrmed the strong relationship
between the number of prenatal visits or the initiation of early
prenatal  care with socioeconomic status and the mother’s
education.27,33 Poverty is a critical determinant of health in
individuals and populations, increasing the vulnerability to
several diseases and is a major barrier to access to health
services, information and preventive measures.34 Income and
education  are strongly associated with health outcomes,35
and the effects of the education level are expressed in different
ways,  such as the perception of health problems, the abil-
ity  to understand health information, the adoption of healthy
lifestyles,  the consumption and utilization of health services,
and  the adherence to therapeutic procedures. HIV infection
prevalence among pregnant women and the incidence of ver-
tical  transmission have been associated with lower urban
quality  of residential neighborhood in Brazil.36 Our study
population was  characterized by low income and educa-
tion  levels and a high predominance of non-white women, 1 4;1  8(3):252–260
accurately representing the impoverished population of Baix-
ada  Fluminense. Despite the signiﬁcant decrease in poverty
intensity during the last years in Brazil, serious social, eco-
nomic  and cultural inequities continue to plague the country.
These  inequities include disparities related to the quality
of  health services, which are fairly evident in prenatal ser-
vices  and are still reﬂected in the insufﬁcient effective access
to  PMTCT interventions. In order to improve engagement
to  care, PMTCT programs  may  need to evaluate alternative
strategies such as incentives and additional services, includ-
ing  enhanced education on PMTCT and sexual transmission
of  HIV. Interventions that improve the engagement of preg-
nant  women in HIV care and treatment programs  are urgently
needed  to achieve the WHO  goal of zero mother-to-child HIV
transmission.37
Importantly, a high prevalence of multiparity (75%) and
abortion  (36.6%) was  observed in this cohort, despite the high
proportion  of women under the age of 24, indicating the
insufﬁciency of adequate family planning services suitable
for  this population. According to data from the 2006 National
Household Sample Survey (Pesquisa Nacional por Amostra de
Domicílios – PNAD), the overall fertility rate in 2005 was  2.1
children  per woman  of childbearing age; it ranged from four
(for  women  with up to 3 years of schooling) to 1.5 (for those
who  had eight or more38 years of schooling). In this context,
access to comprehensive family planning services tailored to
the speciﬁc needs of the HIV-infected population is a key com-
ponent  for effective PMTCT.
Notably,  although the majority of the women (75.3%) were
living  with their partners at the time of inclusion in the cohort,
only  47.1% were  aware of their HIV serostatus, and of these
women,  39.9% had an HIV-uninfected sexual partner, high-
lighting  the substantial risk for HIV sexual transmission in
these  serodiscordant relationships and the critical need to
implement  early ART in these situations, given the 96% reduc-
tion  in the risk of HIV transmission.39 Furthermore, untreated
HIV  infection has a negative impact on health throughout the
course  of the infection.40 Taken together, these data support
the  revised PMTCT recommendations of the Brazilian Ministry
of  Health, which recommend ART postpartum maintenance
for  all women who started it during pregnancy, regardless
of  the CD4 cell counts.41 The evidence that pregnancy dou-
bles  the risk of HIV transmission from pregnant women  to
their  partners42 and the high prevalence of multiparity (75%)
observed  in this study population further reiterate this strat-
egy.
This  study has several limitations. As the study was  con-
ducted  at a single center, the study population could not be
representative of children exposed to MTCT throughout the
state  of Rio de Janeiro. However, this may  be offset, as the
chosen  center, HGNI, receives the greatest regional demand
for  HIV-exposed children in the Baixada Fluminense area. The
retrospective  nature of our study has not allowed for captur-
ing  data on the barriers to PMTCT and to minimize the lost to
follow-up.  As our data were collected from clinical records and
registries,  there were missing values, which we  believe haveable  important data as viral load; thus, we  could not access
the  association between viral load and mode of delivery and
its  appropriateness.
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The results from this study reﬂect the reality of fragmented
ccess to PMTCT interventions in Baixada Fluminense, where
he  municipalities with the lowest levels of development
cross the Rio de Janeiro State are located; approximately 25%
f  the population of Nova Iguac¸u  and Duque de Caxias are
elow  the poverty line.
Our  data provide critical insights to better understand
razil’s low overall performance in PMTCT and may  help
xplain  some of the factors related to the disconcerting occur-
ence  of approximately 500 cases of AIDS in children under
he  age of ﬁve in Brazil.2 Despite the success of the Brazilian
rogram for universal access to ART, the PMTCT program has
ncountered  critical hurdles related to the health care system,
hich  is still deﬁcient and marred by serious social inequities
egarding access to quality health care.33 In this context, equal
ccess  to qualiﬁed health services is essential and will posi-
ively  inﬂuence the cascade of access to PMTCT interventions
nd  decrease the number of pediatric AIDS cases in Brazil.
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